Ventas price target raised to $52.50 from $49 at Morgan Stanley

Morgan Stanley analyst Ronald Kamdem raised the firm’s price target on Ventas to $52.50 from $49 and keeps an Equal Weight rating on the shares. Senior housing occupancy growth beat expectations in Q1 and June updates suggest further acceleration in Q2, notes the analyst, who expects “solid” Q2 results with upside risk to estimates and guidance raises from the Healthcare REITs.